Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biofrontera Inc. stock logo
BFRI
Biofrontera
$1.04
-3.7%
$0.75
$0.54
$2.22
$10.95M0.43176,627 shs71,638 shs
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
$3.88
-6.3%
$4.11
$3.22
$53.10
$7.20M2.9636,848 shs44,385 shs
IMAC Holdings, Inc. stock logo
IMAC
IMAC
$0.06
$0.05
$0.75
$1.65
$1.59M-0.88708,132 shs2,832 shs
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
$0.35
-0.9%
$0.35
$0.29
$2.47
$8.18M1.3590,432 shs82,535 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biofrontera Inc. stock logo
BFRI
Biofrontera
-3.70%-1.89%+50.70%+44.44%-13.33%
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
-6.28%-13.37%+6.89%-69.74%-71.26%
IMAC Holdings, Inc. stock logo
IMAC
IMAC
0.00%0.00%-3.21%+65.29%-96.55%
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
-0.93%-2.72%-2.75%+0.06%-85.29%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biofrontera Inc. stock logo
BFRI
Biofrontera
1.6918 of 5 stars
3.53.00.00.00.60.00.6
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
3.1181 of 5 stars
3.55.00.00.00.01.70.6
IMAC Holdings, Inc. stock logo
IMAC
IMAC
N/AN/AN/AN/AN/AN/AN/AN/A
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
1.9432 of 5 stars
2.83.00.00.00.02.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biofrontera Inc. stock logo
BFRI
Biofrontera
3.00
Buy$2.75164.42% Upside
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
3.00
Buy$60.001,446.39% Upside
IMAC Holdings, Inc. stock logo
IMAC
IMAC
0.00
N/AN/AN/A
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
1.50
Reduce$0.4528.50% Upside

Current Analyst Ratings Breakdown

Latest IMAC, TSBX, BFRI, and CDIO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Biofrontera Inc. stock logo
BFRI
Biofrontera
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$7.00 ➝ $2.75
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biofrontera Inc. stock logo
BFRI
Biofrontera
$38.00M0.28N/AN/A$0.57 per share1.82
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
$19.90K339.03N/AN/A$7.10 per share0.55
IMAC Holdings, Inc. stock logo
IMAC
IMAC
$15.22M0.10N/AN/A$0.69 per share0.09
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
N/AN/AN/AN/A$1.36 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biofrontera Inc. stock logo
BFRI
Biofrontera
-$17.76M-$2.26N/AN/AN/A-30.33%-305.13%-82.67%8/13/2025 (Estimated)
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
-$8.38MN/A0.00N/A-28,539.39%-84.55%-74.63%8/11/2025 (Estimated)
IMAC Holdings, Inc. stock logo
IMAC
IMAC
-$10.54MN/A0.00N/AN/A-75.40%-52.17%-34.51%N/A
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
-$70.84M-$2.73N/AN/AN/AN/A-162.79%-124.10%8/13/2025 (Estimated)

Latest IMAC, TSBX, BFRI, and CDIO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Biofrontera Inc. stock logo
BFRI
Biofrontera
-$0.45N/AN/AN/A$8.30 millionN/A
8/13/2025Q2 2025
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
-$0.16N/AN/AN/AN/AN/A
8/11/2025N/A
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
-$1.80N/AN/AN/A$0.08 millionN/A
5/15/2025Q1 2025
Biofrontera Inc. stock logo
BFRI
Biofrontera
-$0.14-$0.47-$0.33-$0.47$10.55 million$8.59 million
5/15/2025Q1 2025
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
-$0.06-$0.97-$0.91-$0.97$0.05 million$0.00 million
5/8/2025Q1 2025
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
-$0.26-$0.51-$0.25-$0.51N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biofrontera Inc. stock logo
BFRI
Biofrontera
N/AN/AN/AN/AN/A
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
N/AN/AN/AN/AN/A
IMAC Holdings, Inc. stock logo
IMAC
IMAC
N/AN/AN/AN/AN/A
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biofrontera Inc. stock logo
BFRI
Biofrontera
8.99
1.40
0.80
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
N/A
19.47
19.47
IMAC Holdings, Inc. stock logo
IMAC
IMAC
0.01
1.27
1.27
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
N/A
3.70
3.70

Institutional Ownership

CompanyInstitutional Ownership
Biofrontera Inc. stock logo
BFRI
Biofrontera
10.08%
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
8.06%
IMAC Holdings, Inc. stock logo
IMAC
IMAC
24.27%
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
52.51%

Insider Ownership

CompanyInsider Ownership
Biofrontera Inc. stock logo
BFRI
Biofrontera
1.20%
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
22.30%
IMAC Holdings, Inc. stock logo
IMAC
IMAC
10.00%
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
32.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biofrontera Inc. stock logo
BFRI
Biofrontera
7010.14 million10.02 millionNo Data
Cardio Diagnostics Holdings, Inc. stock logo
CDIO
Cardio Diagnostics
11.74 million1.35 millionNot Optionable
IMAC Holdings, Inc. stock logo
IMAC
IMAC
10626.49 million23.84 millionNot Optionable
Turnstone Biologics Corp. stock logo
TSBX
Turnstone Biologics
8223.14 million15.71 millionNot Optionable

Recent News About These Companies

Turnstone Biologics Corp. (TSBX) - Yahoo Finance
Turnstone Biologics reports Q4 EPS (56c) vs (73c) last year
Turnstone Biologics to explore strategic alternatives
Turnstone Biologics downgraded to Neutral from Overweight at Piper Sandler

New MarketBeat Followers Over Time

Media Sentiment Over Time

Biofrontera stock logo

Biofrontera NASDAQ:BFRI

$1.04 -0.04 (-3.52%)
As of 08/1/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Cardio Diagnostics stock logo

Cardio Diagnostics NASDAQ:CDIO

$3.88 -0.26 (-6.28%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$4.00 +0.13 (+3.22%)
As of 08/1/2025 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

IMAC stock logo

IMAC NASDAQ:IMAC

$0.06 0.00 (0.00%)
As of 07/31/2025

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.

Turnstone Biologics stock logo

Turnstone Biologics NASDAQ:TSBX

$0.35 0.00 (-0.93%)
Closing price 08/1/2025 03:47 PM Eastern
Extended Trading
$0.35 +0.00 (+0.51%)
As of 08/1/2025 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, head and neck cancer and uveal melanoma, as well as an investigator sponsored trials to treat colorectal cancer, head and neck cancer, and cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. The company was founded in 2014 and is based in LA Jolla, California.